Cart
sales@molnova.com
GSK3-IN-2
CAS No. 380450-97-5
GSK3-IN-2( —— )
Catalog No. M36509 CAS No. 380450-97-5
GSK3-IN-2 is a potent GSK3 inhibitor for the treatment of diabetes and neurodegenerative diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 109 | Get Quote |
|
| 5MG | 168 | Get Quote |
|
| 10MG | 278 | Get Quote |
|
| 25MG | 542 | Get Quote |
|
| 50MG | 772 | Get Quote |
|
| 100MG | 1044 | Get Quote |
|
| 500MG | 2097 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGSK3-IN-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK3-IN-2 is a potent GSK3 inhibitor for the treatment of diabetes and neurodegenerative diseases.
-
DescriptionGSK3-IN-2 (compound 8) is a potent GSK3 inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayPI3K/Akt/mTOR signaling
-
TargetGSK-3
-
RecptorGSK-3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number380450-97-5
-
Formula Weight313.42
-
Molecular FormulaC17H19N3OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1C=2C(C3=C(NC2CC(C)(C)C1)NN=C3C)C=4C=CSC4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Edward Scolnick, et al. Uses of paralog-selective inhibitors of gsk3 kinases. US20160375006A1.
molnova catalog
related products
-
MeBIO
MeBIO is an agonist of aryl hydrocarbon receptor, with IC50 of 44 and 55 μM for GSK-3 and CDK1/CyclinB, respectively. MeBIO does not affect GSK-3β.
-
CHIR-99021 monohydro...
A potent, specific GSK-3 inhibitor with IC50 of 5 nM and 10 nM for GSK3β and GSK3α, respectively.
-
TDZD-8
A potent, selective, non-ATP competitive GSK-3β inhibitor with IC50 of 2 uM; displays no activity against PKA, CK-2, PKC, and CDK1 (IC50>100 uM).
